Continuity Biosciences Invests in PinPrint, Inc., Expanding into Aesthetic and Cosmetic Drug Delivery

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ContinuityBiosciences

More Like This

PR Newswire associated0

Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies

Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation

PR Newswire associated0

Crown Aesthetics Announces Groundbreaking Study on Skin Microbiome-Optimized BIOJUVE™ Regimen

Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned

PR Newswire associated0

CROWN AESTHETICS PROVIDES CAVENDISH CLINICS WITH AWARD-WINNING SKINPEN® PRECISION TO UPGRADE ITS MICRONEEDLING DEVICE OFFERING

PR Newswire associated0

Tetra Pharm Technologies and Glysious Announce Collaboration to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System

PR Newswire associated0

SkinPen® Precision Now Available through DUBIMED in the Gulf States

Kindeva Drug Delivery Completes Registration Batch at State-of-the-Art Aseptic Injectable Fill-Finish Facility